Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
49
NCT02649751
Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Phase: Phase 2
Role: Collaborator
Start: Feb 22, 2016
Completion: Jul 26, 2018